Retour

OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing

News Oak Hill Advisors

Oak Hill Advisors (OHA) has provided a $250 million term loan facility to Emergent BioSolutions Inc. (EBS) to refinance its existing credit facility. The new debt financing is a crucial step in Emergent's plan to stabilize its financial profile.

GlobeNewswire Inc. • 04/09/2024 à 23:51:00
Emergent Biosolutions, Inc.
Adresse: 400 PROFESSIONAL DR, SUITE 400
Code postal: 20879
Ville: GAITHERSBURG
Region: MD
Numéro de telephone: 240-631-3200
Site internet: https://www.emergentbiosolutions.com
Status: Active
Info de l'entreprise

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Date de référencement2006-11-15
MarchéStocks
LocaleUS
Echange principalXNYS
TypeCS
DeviseUSD
CIK0001367644
Composite figiBBG000GW06J7
Share Class figiBBG001SP1G40
Market Cap394,061,912 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employés1600
Share Class Shares Outstanding52400000
Weighted Shares Outstanding52401850
Round Lot100
Date de mise à jour2024-09-07
Stats
Historique
PériodeVarPlus hautPlus bas
1 semaine
-12.03%
8.7
7.717
1 mois
26.34%
8.967
7.095
3 mois
22.78%
6.4099
5.75
6 mois
167.73%
2.86
1.8201
1 an
68.93%
4.58
1.42
3 ans
-87.8%
61.25
1.42
5 ans
-86.86%
57.285
1.42
10 ans
-67.56%
23.05
1.42
Actions
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-12-11 UNPUB
Assets 2,949,800,000 2,178,800,000 1,893,100,000 UNPUB
Current Assets 1,221,300,000 777,700,000 720,800,000 UNPUB
Current Liabilities 1,215,700,000 693,200,000 664,000,000 UNPUB
Equity 1,202,600,000 956,300,000 697,200,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 1,202,600,000 956,300,000 697,200,000 UNPUB
Liabilities 1,747,200,000 1,222,500,000 1,195,900,000 UNPUB
Liabilities And Equity 2,949,800,000 2,178,800,000 1,893,100,000 UNPUB
Noncurrent Assets 1,728,500,000 1,401,100,000 1,172,300,000 UNPUB
Noncurrent Liabilities 531,500,000 529,300,000 531,900,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-12-11 UNPUB
Exchange Gains/Losses -200,000 -600,000 1,100,000 UNPUB
Net Cash Flow -209,800,000 -344,200,000 -800,000 UNPUB
Net Cash Flow, Continuing -209,600,000 -343,600,000 -1,900,000 UNPUB
Net Cash Flow From Financing Activities -10,500,000 -486,900,000 -43,000,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -10,500,000 -486,900,000 -43,000,000 UNPUB
Net Cash Flow From Investing Activities -15,100,000 257,700,000 -18,900,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -15,100,000 257,700,000 -18,900,000 UNPUB
Net Cash Flow From Operating Activities -184,000,000 -114,400,000 60,000,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -184,000,000 -114,400,000 60,000,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-12-11 UNPUB
Comprehensive Income/Loss -185,100,000 -263,900,000 -264,400,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -185,100,000 -263,900,000 -264,400,000 UNPUB
Other Comprehensive Income/Loss -185,100,000 -263,900,000 -264,400,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent -2,100,000 -2,600,000 -1,000,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-09 2023-12-11 UNPUB
Basic Earnings Per Share -4 -5 -5 UNPUB
Benefits Costs and Expenses 326,200,000 588,100,000 536,400,000 UNPUB
Cost Of Revenue 155,100,000 190,600,000 176,800,000 UNPUB
Costs And Expenses 326,200,000 588,100,000 536,400,000 UNPUB
Diluted Earnings Per Share -4 -5 -5 UNPUB
Gross Profit 3,500,000 140,700,000 87,200,000 UNPUB
Income/Loss From Continuing Operations After Tax -183,000,000 -261,300,000 -263,400,000 UNPUB
Income/Loss From Continuing Operations Before Tax -161,100,000 -250,200,000 -265,900,000 UNPUB
Income Tax Expense/Benefit 21,900,000 11,100,000 -2,500,000 UNPUB
Interest Expense, Operating 17,900,000 28,600,000 19,700,000 UNPUB
Net Income/Loss -183,000,000 -261,300,000 -263,400,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -183,000,000 -261,300,000 -263,400,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -183,000,000 -261,300,000 -263,400,000 UNPUB
Operating Expenses 151,600,000 433,600,000 329,300,000 UNPUB
Operating Income/Loss -148,100,000 -292,900,000 -242,100,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 165,100,000 337,900,000 270,500,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-29 2022-08-02 2022-11-09 2023-03-01
Assets 2,780,400,000 2,735,400,000 2,908,500,000 3,166,600,000
Current Assets 1,100,300,000 1,084,200,000 1,118,500,000 1,210,700,000
Current Liabilities 249,200,000 276,700,000 268,400,000 1,229,900,000
Equity 1,575,300,000 1,513,200,000 1,449,300,000 1,383,000,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,575,300,000 1,513,200,000 1,449,300,000 1,383,000,000
Liabilities 1,205,100,000 1,222,200,000 1,459,200,000 1,783,600,000
Liabilities And Equity 2,780,400,000 2,735,400,000 2,908,500,000 3,166,600,000
Noncurrent Assets 1,680,100,000 1,651,200,000 1,790,000,000 1,955,900,000
Noncurrent Liabilities 0 0 1,190,800,000 553,700,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-29 2022-08-02 2022-11-09 2023-03-01
Exchange Gains/Losses -300,000 700,000 -1,000,000 500,000
Net Cash Flow -140,300,000 -77,700,000 -117,300,000 66,300,000
Net Cash Flow, Continuing -140,000,000 -78,400,000 -116,300,000 65,800,000
Net Cash Flow From Financing Activities -70,500,000 -30,700,000 229,300,000 481,200,000
Net Cash Flow From Financing Activities, Continuing -70,500,000 -30,700,000 229,300,000 481,200,000
Net Cash Flow From Investing Activities -32,200,000 -32,100,000 -271,600,000 -381,300,000
Net Cash Flow From Investing Activities, Continuing -32,200,000 -32,100,000 -271,600,000 -381,300,000
Net Cash Flow From Operating Activities -37,300,000 -15,600,000 -74,000,000 -34,100,000
Net Cash Flow From Operating Activities, Continuing -37,300,000 -15,600,000 -74,000,000 -34,100,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-29 2022-08-02 2022-11-09 2023-03-01
Comprehensive Income/Loss 3,100,000 -53,200,000 -74,800,000 -204,600,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 3,100,000 -53,200,000 -74,800,000 -204,600,000
Other Comprehensive Income/Loss 3,100,000 -53,200,000 -74,800,000 -204,600,000
Other Comprehensive Income/Loss Attributable To Parent 6,800,000 3,200,000 900,000 19,200,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-04-29 2022-08-02 2022-11-09 2023-03-01
Basic Earnings Per Share 0 -1 -2 -4
Benefits Costs and Expenses 311,300,000 325,500,000 303,900,000 1,342,600,000
Cost Of Revenue 165,500,000 177,100,000 166,000,000 693,700,000
Costs And Expenses 311,300,000 325,500,000 303,900,000 1,342,600,000
Diluted Earnings Per Share 0 -1 -2 -4
Gross Profit 142,000,000 65,600,000 74,000,000 385,800,000
Income/Loss From Continuing Operations After Tax -3,700,000 -56,400,000 -75,700,000 -223,800,000
Income/Loss From Continuing Operations Before Tax -3,800,000 -82,800,000 -63,900,000 -221,700,000
Income Tax Expense/Benefit -100,000 -26,400,000 11,800,000 2,100,000
Interest Expense, Operating 8,200,000 7,800,000 8,500,000 37,300,000
Net Income/Loss -3,700,000 -56,400,000 -75,700,000 -223,800,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,700,000 -56,400,000 -75,700,000 -223,800,000
Net Income/Loss Available To Common Stockholders, Basic -3,700,000 -56,400,000 -75,700,000 -223,800,000
Operating Expenses 135,600,000 137,600,000 116,000,000 558,500,000
Operating Income/Loss 6,400,000 -72,000,000 -42,000,000 -172,700,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 307,500,000 242,700,000 240,000,000 1,120,900,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-30 2021-07-30 2021-11-05 2022-02-25
Assets 2,900,100,000 2,915,200,000 2,867,500,000 2,959,000,000
Current Assets 1,181,100,000 1,162,100,000 1,111,500,000 1,272,100,000
Current Liabilities 370,200,000 377,800,000 365,400,000 373,800,000
Equity 1,522,800,000 1,543,700,000 1,522,700,000 1,619,000,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,522,800,000 1,543,700,000 1,522,700,000 1,619,000,000
Liabilities 1,377,300,000 1,371,500,000 1,344,800,000 1,340,000,000
Liabilities And Equity 2,900,100,000 2,915,200,000 2,867,500,000 2,959,000,000
Noncurrent Assets 1,719,000,000 1,753,100,000 1,756,000,000 1,686,900,000
Noncurrent Liabilities 0 0 979,400,000 966,200,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-30 2021-07-30 2021-11-05 2022-02-25
Exchange Gains/Losses -300,000 200,000 -200,000 -300,000
Net Cash Flow -73,500,000 -100,300,000 -43,700,000 -45,200,000
Net Cash Flow, Continuing -73,200,000 -100,500,000 -43,500,000 -44,900,000
Net Cash Flow From Financing Activities -22,200,000 -3,800,000 -5,000,000 -141,000,000
Net Cash Flow From Financing Activities, Continuing -22,200,000 -3,800,000 -5,000,000 -141,000,000
Net Cash Flow From Investing Activities -56,100,000 -67,000,000 -55,200,000 -225,000,000
Net Cash Flow From Investing Activities, Continuing -56,100,000 -67,000,000 -55,200,000 -225,000,000
Net Cash Flow From Operating Activities 5,100,000 -29,700,000 16,700,000 321,100,000
Net Cash Flow From Operating Activities, Continuing 5,100,000 -29,700,000 16,700,000 321,100,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-30 2021-07-30 2021-11-05 2022-02-25
Comprehensive Income/Loss 70,600,000 6,600,000 -33,400,000 240,100,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 70,600,000 6,600,000 -33,400,000 240,100,000
Other Comprehensive Income/Loss 70,600,000 6,600,000 -33,400,000 240,100,000
Other Comprehensive Income/Loss Attributable To Parent 900,000 2,000,000 -700,000 9,200,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-30 2021-07-30 2021-11-05 2022-02-25
Basic Earnings Per Share 1 0 -1 4
Benefits Costs and Expenses 257,800,000 390,300,000 374,500,000 1,478,300,000
Cost Of Revenue 99,300,000 227,800,000 UNPUB UNPUB
Costs And Expenses 257,800,000 390,300,000 374,500,000 1,478,300,000
Diluted Earnings Per Share 1 0 -1 4
Gross Profit 243,700,000 169,700,000 UNPUB UNPUB
Income/Loss From Continuing Operations After Tax 69,700,000 4,600,000 -32,700,000 230,900,000
Income/Loss From Continuing Operations Before Tax 85,200,000 7,200,000 -45,500,000 314,400,000
Income Tax Expense/Benefit 15,500,000 2,600,000 -12,800,000 83,500,000
Interest Expense, Operating 8,500,000 8,600,000 8,400,000 34,500,000
Net Income/Loss 69,700,000 4,600,000 -32,700,000 230,900,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 69,700,000 4,600,000 -32,700,000 230,900,000
Net Income/Loss Available To Common Stockholders, Basic 69,700,000 4,600,000 -32,700,000 230,900,000
Operating Expenses 148,300,000 155,200,000 363,700,000 1,440,100,000
Operating Income/Loss 95,400,000 14,500,000 -34,700,000 352,600,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 343,000,000 397,500,000 329,000,000 1,792,700,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-01 2020-07-31 2020-11-06 2021-02-19
Assets 2,278,700,000 2,466,100,000 2,616,300,000 2,883,200,000
Current Assets 626,600,000 795,900,000 958,800,000 1,195,900,000
Current Liabilities 207,100,000 293,700,000 299,300,000 384,500,000
Equity 1,074,800,000 1,198,800,000 1,251,500,000 1,447,000,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,074,800,000 1,198,800,000 1,251,500,000 1,447,000,000
Liabilities 1,203,900,000 1,267,300,000 1,364,800,000 1,436,200,000
Liabilities And Equity 2,278,700,000 2,466,100,000 2,616,300,000 2,883,200,000
Noncurrent Assets 1,652,100,000 1,670,200,000 1,657,500,000 1,687,300,000
Noncurrent Liabilities 0 0 1,065,500,000 1,051,700,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-01 2020-07-31 2020-11-06 2021-02-19
Exchange Gains/Losses 100,000 -200,000 -400,000 -1,000,000
Net Cash Flow 13,700,000 87,300,000 146,200,000 453,500,000
Net Cash Flow, Continuing 13,600,000 87,500,000 146,600,000 454,500,000
Net Cash Flow From Financing Activities -20,000,000 4,700,000 87,100,000 69,500,000
Net Cash Flow From Financing Activities, Continuing -20,000,000 4,700,000 87,100,000 69,500,000
Net Cash Flow From Investing Activities -24,200,000 -45,100,000 -45,700,000 -151,000,000
Net Cash Flow From Investing Activities, Continuing -24,200,000 -45,100,000 -45,700,000 -151,000,000
Net Cash Flow From Operating Activities 57,800,000 127,900,000 105,200,000 536,000,000
Net Cash Flow From Operating Activities, Continuing 57,800,000 127,900,000 105,200,000 536,000,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-01 2020-07-31 2020-11-06 2021-02-19
Comprehensive Income/Loss -12,500,000 92,700,000 39,500,000 289,700,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -23,800,000 91,700,000 40,300,000 289,700,000
Other Comprehensive Income/Loss 0 0 0 289,700,000
Other Comprehensive Income/Loss Attributable To Parent -11,300,000 -1,000,000 800,000 -15,400,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-01 2020-07-31 2020-11-06 2021-02-19
Basic Earnings Per Share 0 2 1 6
Benefits Costs and Expenses 0 0 0 1,148,200,000
Cost Of Revenue 76,900,000 129,800,000 149,000,000 524,000,000
Costs And Expenses 204,100,000 268,700,000 323,900,000 1,148,200,000
Diluted Earnings Per Share 0 2 1 6
Gross Profit 115,600,000 264,900,000 236,200,000 1,031,400,000
Income/Loss From Continuing Operations After Tax -12,500,000 92,700,000 39,500,000 305,100,000
Income/Loss From Continuing Operations Before Tax -21,300,000 120,700,000 55,000,000 407,200,000
Income Tax Expense/Benefit -8,800,000 28,000,000 15,500,000 102,100,000
Interest Expense, Operating 8,600,000 6,400,000 7,600,000 31,300,000
Net Income/Loss -12,500,000 92,700,000 39,500,000 305,100,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -12,500,000 92,700,000 39,500,000 305,100,000
Net Income/Loss Available To Common Stockholders, Basic -12,500,000 92,700,000 39,500,000 305,100,000
Operating Expenses 204,100,000 268,700,000 323,900,000 597,600,000
Operating Income/Loss -11,600,000 126,000,000 61,300,000 433,800,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 192,500,000 394,700,000 385,200,000 1,555,400,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-02 2019-11-07 2020-02-25
Assets 2,153,700,000 2,321,300,000 2,333,800,000 2,327,300,000
Current Assets 528,500,000 692,700,000 700,000,000 686,200,000
Current Liabilities 248,400,000 301,200,000 275,300,000 216,300,000
Equity 987,500,000 988,900,000 1,035,000,000 1,088,500,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 987,300,000 988,900,000 1,035,000,000 1,088,500,000
Liabilities 1,166,200,000 1,332,400,000 1,298,800,000 1,238,800,000
Liabilities And Equity 2,153,700,000 2,321,300,000 2,333,800,000 2,327,300,000
Noncurrent Assets 1,625,200,000 1,628,600,000 1,633,800,000 1,641,100,000
Noncurrent Liabilities 0 0 1,023,500,000 1,022,500,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-02 2019-11-07 2020-02-25
Exchange Gains/Losses UNPUB UNPUB -100,000 400,000
Net Cash Flow 25,000,000 40,200,000 -38,200,000 55,600,000
Net Cash Flow, Continuing 25,000,000 40,200,000 -38,100,000 55,200,000
Net Cash Flow From Financing Activities -58,400,000 100,100,000 -19,700,000 -35,900,000
Net Cash Flow From Financing Activities, Continuing -58,400,000 100,100,000 -19,700,000 -35,900,000
Net Cash Flow From Investing Activities -21,400,000 -24,100,000 -15,300,000 -96,900,000
Net Cash Flow From Investing Activities, Continuing -21,400,000 -24,100,000 -15,300,000 -96,900,000
Net Cash Flow From Operating Activities 104,800,000 -35,800,000 -3,100,000 188,000,000
Net Cash Flow From Operating Activities, Continuing 104,800,000 -35,800,000 -3,100,000 188,000,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-02 2019-11-07 2020-02-25
Comprehensive Income/Loss -25,000,000 -9,500,000 43,200,000 50,100,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -26,100,000 -10,000,000 39,100,000 50,100,000
Other Comprehensive Income/Loss 1,000,000 -500,000 -4,100,000 50,100,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -4,400,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-02 2019-11-07 2020-02-25
Basic Earnings Per Share -1 0 1 1
Benefits Costs and Expenses 0 0 0 1,028,600,000
Cost Of Revenue 91,800,000 100,800,000 108,000,000 433,500,000
Costs And Expenses 0 0 0 1,028,600,000
Diluted Earnings Per Share -1 0 1 1
Gross Profit -27,400,000 -7,000,000 70,700,000 672,500,000
Income/Loss From Continuing Operations After Tax -26,000,000 -9,500,000 43,200,000 54,500,000
Income/Loss From Continuing Operations Before Tax -37,800,000 -15,100,000 58,900,000 77,400,000
Income Tax Expense/Benefit -11,800,000 -5,600,000 15,700,000 22,900,000
Interest Expense, Operating 9,600,000 9,500,000 10,300,000 38,400,000
Net Income/Loss -26,000,000 -9,500,000 43,200,000 54,500,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -26,100,000 -9,500,000 43,200,000 54,500,000
Net Income/Loss Available To Common Stockholders, Basic -26,100,000 -9,500,000 43,200,000 54,500,000
Operating Expenses 217,800,000 250,200,000 241,100,000 991,900,000
Operating Income/Loss -27,200,000 -7,000,000 70,700,000 114,100,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 190,600,000 243,200,000 311,800,000 1,106,000,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-04 2018-08-03 2018-11-02 2019-02-22
Assets 1,068,467,000 1,138,891,000 1,173,623,000 2,229,400,000
Current Assets 476,649,000 541,308,000 563,148,000 620,800,000
Current Liabilities 86,870,000 96,813,000 102,014,000 200,400,000
Equity 881,280,000 938,346,000 966,649,000 1,010,900,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 881,280,000 938,346,000 966,649,000 1,010,900,000
Liabilities 187,187,000 200,545,000 206,974,000 1,218,500,000
Liabilities And Equity 1,068,467,000 1,138,891,000 1,173,623,000 2,229,400,000
Noncurrent Assets 591,818,000 597,583,000 610,475,000 1,608,600,000
Noncurrent Liabilities 100,317,000 103,732,000 104,960,000 1,018,100,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-04 2018-08-03 2018-11-02 2019-02-22
Exchange Gains/Losses 45,000 -141,000 -471,000 -200,000
Net Cash Flow -14,686,000 26,631,000 149,121,000 -66,900,000
Net Cash Flow, Continuing -14,731,000 26,772,000 149,592,000 -66,700,000
Net Cash Flow From Financing Activities -2,125,000 3,168,000 1,677,000 788,700,000
Net Cash Flow From Financing Activities, Continuing -2,125,000 3,168,000 1,677,000 788,700,000
Net Cash Flow From Investing Activities -11,615,000 -10,978,000 -26,058,000 -897,200,000
Net Cash Flow From Investing Activities, Continuing -11,615,000 -10,978,000 -26,058,000 -897,200,000
Net Cash Flow From Operating Activities -991,000 34,582,000 173,973,000 41,800,000
Net Cash Flow From Operating Activities, Continuing -991,000 34,582,000 173,973,000 41,800,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-04 2018-08-03 2018-11-02 2019-02-22
Comprehensive Income/Loss -4,461,000 51,309,000 20,695,000 60,900,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,461,000 51,309,000 20,695,000 60,900,000
Other Comprehensive Income/Loss 447,000 51,309,000 20,695,000 -1,800,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-04 2018-08-03 2018-11-02 2019-02-22
Basic Earnings Per Share 0 1 0 1
Benefits Costs and Expenses 122,700,000 170,100,000 152,800,000 700,900,000
Cost Of Revenue 58,044,000 89,173,000 73,232,000 322,300,000
Costs And Expenses 122,700,000 170,100,000 152,800,000 700,900,000
Diluted Earnings Per Share 0 1 0 1
Gross Profit -9,500,000 66,800,000 21,300,000 460,100,000
Income/Loss From Continuing Operations After Tax -4,900,000 50,100,000 20,900,000 62,700,000
Income/Loss From Continuing Operations Before Tax -9,423,000 65,821,000 21,559,000 81,500,000
Income Tax Expense/Benefit -4,515,000 15,677,000 614,000 18,800,000
Interest Expense, Operating 234,000 1,008,000 642,000 9,900,000
Net Income/Loss -4,908,000 50,144,000 20,945,000 62,700,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,908,000 50,144,000 20,945,000 62,700,000
Net Income/Loss Available To Common Stockholders, Basic -4,908,000 50,144,000 20,945,000 62,700,000
Operating Expenses -4,600,000 16,700,000 400,000 692,600,000
Operating Income/Loss -9,485,000 66,776,000 21,310,000 89,800,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 117,800,000 220,200,000 173,700,000 782,400,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-08-04 2017-11-03 2018-02-23
Assets 951,639,000 970,483,000 1,024,202,000 1,070,206,000
Current Assets 489,166,000 509,741,000 556,034,000 485,389,000
Current Liabilities 67,706,000 72,926,000 75,432,000 100,068,000
Equity 610,419,000 620,599,000 663,710,000 912,345,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 610,419,000 620,599,000 663,710,000 912,345,000
Liabilities 341,220,000 349,884,000 360,492,000 157,861,000
Liabilities And Equity 951,639,000 970,483,000 1,024,202,000 1,070,206,000
Noncurrent Assets 462,473,000 460,742,000 468,168,000 584,817,000
Noncurrent Liabilities 273,514,000 276,958,000 285,060,000 57,793,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-08-04 2017-11-03 2018-02-23
Exchange Gains/Losses -3,000 -9,000 -62,000 -27,000
Net Cash Flow -1,343,000 45,457,000 25,364,000 -93,221,000
Net Cash Flow, Continuing -1,340,000 45,466,000 25,426,000 -93,194,000
Net Cash Flow From Financing Activities -22,707,000 765,000 4,687,000 -51,401,000
Net Cash Flow From Financing Activities, Continuing -22,707,000 765,000 4,687,000 -51,401,000
Net Cash Flow From Investing Activities -20,304,000 -9,301,000 -12,776,000 -249,932,000
Net Cash Flow From Investing Activities, Continuing -20,304,000 -9,301,000 -12,776,000 -249,932,000
Net Cash Flow From Operating Activities 41,671,000 54,002,000 33,515,000 208,139,000
Net Cash Flow From Operating Activities, Continuing 41,671,000 54,002,000 33,515,000 208,139,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-08-04 2017-11-03 2018-02-23
Comprehensive Income/Loss 11,069,000 4,844,000 33,255,000 83,227,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 11,069,000 4,844,000 33,255,000 83,227,000
Other Comprehensive Income/Loss 584,000 4,844,000 33,255,000 -35,406,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-05 2017-08-04 2017-11-03 2018-02-23
Basic Earnings Per Share 0 0 1 2
Benefits Costs and Expenses 106,373,000 96,156,000 115,883,000 442,240,000
Cost Of Revenue 46,322,000 34,624,000 44,503,000 195,707,000
Costs And Expenses 106,373,000 96,156,000 115,883,000 442,240,000
Diluted Earnings Per Share 0 0 1 2
Gross Profit 14,910,000 8,529,000 47,769,000 365,166,000
Income/Loss From Continuing Operations After Tax 10,485,000 4,616,000 33,551,000 82,594,000
Income/Loss From Continuing Operations Before Tax 13,645,000 6,721,000 46,314,000 118,633,000
Income Tax Expense/Benefit 3,160,000 2,105,000 12,763,000 36,039,000
Interest Expense, Operating 1,938,000 1,805,000 1,991,000 6,590,000
Net Income/Loss 10,485,000 4,616,000 33,551,000 118,633,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 36,039,000
Net Income/Loss Attributable To Parent 10,485,000 4,616,000 33,551,000 82,594,000
Net Income/Loss Available To Common Stockholders, Basic 10,485,000 4,616,000 33,551,000 82,594,000
Operating Expenses 4,425,000 3,913,000 14,218,000 240,881,000
Operating Income/Loss 14,910,000 8,529,000 47,769,000 124,285,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 116,858,000 100,772,000 149,434,000 560,873,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-06 2016-08-05 2016-11-09 2017-02-28
Assets 1,035,897,000 1,056,466,000 932,026,000 970,111,000
Current Assets 528,160,000 528,047,000 479,995,000 510,218,000
Current Liabilities 90,455,000 103,858,000 110,306,000 105,856,000
Equity 666,982,000 672,672,000 547,623,000 596,205,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 666,982,000 672,672,000 547,623,000 596,205,000
Liabilities 368,915,000 383,794,000 384,403,000 373,906,000
Liabilities And Equity 1,035,897,000 1,056,466,000 932,026,000 970,111,000
Noncurrent Assets 507,737,000 528,419,000 452,031,000 459,893,000
Noncurrent Liabilities 278,460,000 279,936,000 274,097,000 268,050,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-06 2016-08-05 2016-11-09 2017-02-28
Exchange Gains/Losses 11,000 157,000 -29,000 129,000
Net Cash Flow 28,221,000 -7,621,000 -34,463,000 -41,282,000
Net Cash Flow, Continuing 28,210,000 -7,778,000 -34,434,000 -41,411,000
Net Cash Flow From Financing Activities 8,629,000 15,366,000 -44,415,000 -18,641,000
Net Cash Flow From Financing Activities, Continuing 8,629,000 15,366,000 -44,415,000 -18,641,000
Net Cash Flow From Investing Activities -18,214,000 -21,032,000 -16,997,000 -76,257,000
Net Cash Flow From Investing Activities, Continuing -18,214,000 -21,032,000 -16,997,000 -76,257,000
Net Cash Flow From Operating Activities 37,795,000 -2,112,000 26,978,000 53,487,000
Net Cash Flow From Operating Activities, Continuing 37,795,000 -2,112,000 26,978,000 53,487,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-06 2016-08-05 2016-11-09 2017-02-28
Comprehensive Income/Loss 2,552,000 -9,875,000 20,848,000 50,158,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 3,991,000 -10,947,000 21,340,000 50,158,000
Other Comprehensive Income/Loss 0 0 0 -1,618,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-06 2016-08-05 2016-11-09 2017-02-28
Basic Earnings Per Share 0 0 1 1
Benefits Costs and Expenses 91,075,000 93,283,000 122,526,000 389,561,000
Cost Of Revenue 28,503,000 35,612,000 39,560,000 131,284,000
Costs And Expenses 91,075,000 93,283,000 122,526,000 389,561,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 21,157,000 -2,042,000 35,478,000 357,498,000
Income/Loss From Continuing Operations After Tax 11,889,000 -2,042,000 20,388,000 62,524,000
Income/Loss From Continuing Operations Before Tax 7,339,000 -14,892,000 33,553,000 99,221,000
Income Tax Expense/Benefit 3,348,000 -3,945,000 13,165,000 36,697,000
Interest Expense, Operating 1,524,000 1,509,000 2,049,000 7,617,000
Net Income/Loss 3,991,000 -10,947,000 21,340,000 51,776,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 3,991,000 -10,947,000 21,340,000 51,776,000
Net Income/Loss Available To Common Stockholders, Basic 3,991,000 -10,947,000 21,340,000 51,776,000
Operating Expenses 9,268,000 93,283,000 15,090,000 251,976,000
Operating Income/Loss 8,561,000 -13,620,000 35,478,000 105,522,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 102,964,000 91,241,000 142,914,000 488,782,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-08 2015-08-06 2015-11-06 2016-02-29
Assets 917,845,000 943,323,000 976,548,000 1,043,592,000
Current Assets 405,811,000 435,488,000 473,490,000 538,612,000
Current Liabilities 80,297,000 86,962,000 88,725,000 99,611,000
Equity 537,878,000 562,251,000 605,312,000 660,017,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 537,878,000 562,251,000 605,312,000 660,017,000
Liabilities 379,967,000 381,072,000 371,236,000 383,575,000
Liabilities And Equity 917,845,000 943,323,000 976,548,000 1,043,592,000
Noncurrent Assets 512,034,000 507,835,000 503,058,000 504,980,000
Noncurrent Liabilities 299,670,000 294,110,000 282,511,000 283,964,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-08 2015-08-06 2015-11-06 2016-02-29
Exchange Gains/Losses -25,000 17,000 -8,000 -150,000
Net Cash Flow -63,984,000 -1,674,000 93,877,000 32,296,000
Net Cash Flow, Continuing -63,959,000 -1,691,000 93,885,000 32,446,000
Net Cash Flow From Financing Activities 10,996,000 6,405,000 3,076,000 33,449,000
Net Cash Flow From Financing Activities, Continuing 10,996,000 6,405,000 3,076,000 33,449,000
Net Cash Flow From Investing Activities -9,082,000 -10,599,000 -13,950,000 -45,462,000
Net Cash Flow From Investing Activities, Continuing -9,082,000 -10,599,000 -13,950,000 -45,462,000
Net Cash Flow From Operating Activities -65,873,000 2,503,000 104,759,000 44,459,000
Net Cash Flow From Operating Activities, Continuing -65,873,000 2,503,000 104,759,000 44,459,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-08 2015-08-06 2015-11-06 2016-02-29
Comprehensive Income/Loss -21,754,000 13,685,000 36,447,000 63,165,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -21,519,000 14,100,000 36,942,000 63,165,000
Other Comprehensive Income/Loss 0 0 0 295,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-08 2015-08-06 2015-11-06 2016-02-29
Basic Earnings Per Share -1 0 1 2
Benefits Costs and Expenses 0 0 0 433,020,000
Cost Of Revenue 18,748,000 27,266,000 38,511,000 124,295,000
Costs And Expenses 91,943,000 104,660,000 111,935,000 433,020,000
Diluted Earnings Per Share -1 0 1 1
Gross Profit 44,885,000 98,846,000 126,429,000 398,494,000
Income/Loss From Continuing Operations After Tax -21,519,000 14,100,000 36,942,000 62,870,000
Income/Loss From Continuing Operations Before Tax -29,789,000 19,600,000 52,076,000 89,769,000
Income Tax Expense/Benefit -8,269,000 5,500,000 15,134,000 26,899,000
Interest Expense, Operating 1,661,000 1,628,000 1,635,000 6,523,000
Net Income/Loss -21,520,000 14,100,000 36,942,000 62,870,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,519,000 14,100,000 36,942,000 62,870,000
Net Income/Loss Available To Common Stockholders, Basic -21,519,000 14,100,000 36,942,000 62,870,000
Operating Expenses 91,943,000 104,660,000 111,935,000 302,455,000
Operating Income/Loss -28,310,000 21,452,000 53,005,000 96,039,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 63,633,000 126,112,000 164,940,000 522,789,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-08 2014-11-10 UNPUB
Assets 823,251,000 837,249,000 869,291,000 UNPUB
Current Assets 327,203,000 345,449,000 383,632,000 UNPUB
Current Liabilities 72,324,000 76,427,000 81,417,000 UNPUB
Equity 477,495,000 487,767,000 513,138,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 477,495,000 487,767,000 513,138,000 UNPUB
Liabilities 345,756,000 349,482,000 356,153,000 UNPUB
Liabilities And Equity 823,251,000 837,249,000 869,291,000 UNPUB
Noncurrent Assets 496,048,000 491,800,000 485,659,000 UNPUB
Noncurrent Liabilities 273,432,000 273,055,000 274,736,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-08 2014-11-10 UNPUB
Exchange Gains/Losses 5,000 -3,000 15,000 UNPUB
Net Cash Flow -19,123,000 7,915,000 74,119,000 UNPUB
Net Cash Flow, Continuing -19,128,000 7,918,000 74,104,000 UNPUB
Net Cash Flow From Financing Activities 192,874,000 1,909,000 402,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 192,874,000 1,909,000 402,000 UNPUB
Net Cash Flow From Investing Activities -182,757,000 -4,810,000 -5,221,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -182,757,000 -4,810,000 -5,221,000 UNPUB
Net Cash Flow From Operating Activities -29,245,000 10,819,000 78,923,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -29,245,000 10,819,000 78,923,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-08 2014-11-10 UNPUB
Comprehensive Income/Loss -20,162,000 5,168,000 21,273,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -20,162,000 5,168,000 21,273,000 UNPUB
Other Comprehensive Income/Loss 74,000 139,000 -559,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-12 2014-08-08 2014-11-10 UNPUB
Basic Earnings Per Share -1 0 1 UNPUB
Benefits Costs and Expenses 82,325,000 102,831,000 108,253,000 UNPUB
Cost Of Revenue 18,997,000 34,507,000 32,423,000 UNPUB
Costs And Expenses 82,325,000 102,831,000 108,253,000 UNPUB
Diluted Earnings Per Share -1 0 0 UNPUB
Gross Profit 34,887,000 75,818,000 105,531,000 UNPUB
Income/Loss From Continuing Operations After Tax -20,236,000 5,029,000 21,832,000 UNPUB
Income/Loss From Continuing Operations Before Tax -28,441,000 7,494,000 29,701,000 UNPUB
Income Tax Expense/Benefit -8,205,000 2,465,000 7,869,000 UNPUB
Interest Expense, Operating 3,535,000 1,721,000 1,810,000 UNPUB
Net Income/Loss -20,236,000 5,029,000 21,832,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -20,236,000 5,029,000 21,832,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -20,236,000 5,029,000 21,832,000 UNPUB
Operating Expenses 60,345,000 67,956,000 74,499,000 UNPUB
Operating Income/Loss -25,458,000 7,862,000 31,032,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 53,884,000 110,325,000 137,954,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-06 2013-11-08 2014-03-10
Assets 538,385,000 555,614,000 595,464,000 626,630,000
Current Assets 237,079,000 248,159,000 234,015,000 273,115,000
Current Liabilities 43,541,000 48,778,000 56,632,000 56,651,000
Equity 435,805,000 449,082,000 466,857,000 489,165,000
Equity Attributable To Noncontrolling Interest 217,000 -448,000 -449,000 -453,000
Equity Attributable To Parent 435,588,000 449,530,000 467,306,000 489,618,000
Liabilities 102,580,000 106,532,000 128,607,000 137,465,000
Liabilities And Equity 538,385,000 555,614,000 595,464,000 626,630,000
Noncurrent Assets 301,306,000 307,455,000 361,449,000 353,515,000
Noncurrent Liabilities 59,039,000 57,754,000 71,975,000 80,814,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-06 2013-11-08 2014-03-10
Exchange Gains/Losses -118,000 161,000 -37,000 -14,000
Net Cash Flow -11,428,000 26,005,000 16,318,000 37,672,000
Net Cash Flow, Continuing -11,310,000 25,844,000 16,355,000 37,686,000
Net Cash Flow From Financing Activities 995,000 -540,000 647,000 8,612,000
Net Cash Flow From Financing Activities, Continuing 995,000 -540,000 647,000 8,612,000
Net Cash Flow From Investing Activities -7,679,000 -6,444,000 -44,417,000 -67,894,000
Net Cash Flow From Investing Activities, Continuing -7,679,000 -6,444,000 -44,417,000 -67,894,000
Net Cash Flow From Operating Activities -4,626,000 32,828,000 60,125,000 96,968,000
Net Cash Flow From Operating Activities, Continuing -4,626,000 32,828,000 60,125,000 96,968,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-06 2013-11-08 2014-03-10
Comprehensive Income/Loss -7,692,000 10,730,000 13,502,000 31,799,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -8,062,000 10,484,000 13,491,000 31,799,000
Other Comprehensive Income/Loss 0 0 0 1,540,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-06 2013-11-08 2014-03-10
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 269,378,000
Cost Of Revenue 5,698,000 16,945,000 20,063,000 62,127,000
Costs And Expenses 56,450,000 67,724,000 70,955,000 269,378,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 37,402,000 65,491,000 69,039,000 250,618,000
Income/Loss From Continuing Operations After Tax -8,062,000 10,484,000 13,491,000 30,259,000
Income/Loss From Continuing Operations Before Tax -13,321,000 14,737,000 18,293,000 43,367,000
Income Tax Expense/Benefit -4,516,000 4,381,000 4,802,000 13,108,000
Interest Expense, Operating 11,000 3,000 0 0
Net Income/Loss -8,805,000 10,356,000 13,491,000 30,259,000
Net Income/Loss Attributable To Noncontrolling Interest -743,000 -128,000 0 -876,000
Net Income/Loss Attributable To Parent -8,062,000 10,484,000 13,491,000 31,135,000
Net Income/Loss Available To Common Stockholders, Basic -8,062,000 10,484,000 13,491,000 31,135,000
Operating Expenses 56,450,000 67,724,000 70,955,000 207,816,000
Operating Income/Loss -13,350,000 14,712,000 18,147,000 42,802,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 43,100,000 82,436,000 89,102,000 312,745,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-08
Assets UNPUB UNPUB UNPUB 564,230,000
Current Assets UNPUB UNPUB UNPUB 263,347,000
Current Liabilities UNPUB UNPUB UNPUB 61,907,000
Equity UNPUB UNPUB UNPUB 442,128,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 770,000
Equity Attributable To Parent UNPUB UNPUB UNPUB 441,358,000
Liabilities UNPUB UNPUB UNPUB 122,102,000
Liabilities And Equity UNPUB UNPUB UNPUB 564,230,000
Noncurrent Assets UNPUB UNPUB UNPUB 300,883,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 60,195,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-08
Exchange Gains/Losses UNPUB UNPUB UNPUB 1,000
Net Cash Flow UNPUB UNPUB UNPUB -2,235,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -2,236,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB -1,765,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB -1,765,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -40,114,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -40,114,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB 39,643,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB 39,643,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-08
Comprehensive Income/Loss UNPUB UNPUB UNPUB 22,708,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 22,708,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 4,565,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-08
Basic Earnings Per Share UNPUB UNPUB UNPUB 1
Benefits Costs and Expenses UNPUB UNPUB UNPUB 249,823,000
Cost Of Revenue UNPUB UNPUB UNPUB 46,077,000
Costs And Expenses UNPUB UNPUB UNPUB 249,823,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB 1
Gross Profit UNPUB UNPUB UNPUB 235,811,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB 18,143,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB 32,065,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 13,922,000
Interest Expense, Operating UNPUB UNPUB UNPUB 6,000
Net Income/Loss UNPUB UNPUB UNPUB 18,143,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB -5,381,000
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 23,524,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB 23,524,000
Operating Expenses UNPUB UNPUB UNPUB 205,844,000
Operating Income/Loss UNPUB UNPUB UNPUB 29,967,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 281,888,000
Calendrier économique
6 Septembre 2024 (heure UTC) Actuel Précédent Consensus
★
15:30
United States
SEP 03
-27700.000
-32700.000
★
15:30
United States
SEP 03
46100.000
52200.000
★
15:30
United States
SEP 03
-48800.000
-81900.000
★
15:30
United States
SEP 03
-100300.000
-92200.000
★★
15:30
United States
SEP 03
26000.000
21400.000
★
15:30
United States
SEP 03
287600.000
294400.000
★
15:30
United States
SEP 03
177000.000
226700.000
★
15:30
United States
SEP 03
-90500.000
-148500.000
★
15:30
United States
SEP 03
-162000.000
-184300.000
★
15:30
United States
SEP 03
13000.000
17100.000
★
15:30
United States
SEP 03
2300.000
2200.000
★
15:30
United States
★
15:30
United States
★★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:EBS240621P00010000 OPASPS Put American 100 10 BATO 2024-06-21
O:EBS240621C00010000 OCASPS Call American 100 10 BATO 2024-06-21
O:EBS240621P00007500 OPASPS Put American 100 7.5 BATO 2024-06-21
O:EBS240621P00005000 OPASPS Put American 100 5 BATO 2024-06-21
O:EBS240621P00002500 OPASPS Put American 100 2.5 BATO 2024-06-21
O:EBS240621C00007500 OCASPS Call American 100 7.5 BATO 2024-06-21
O:EBS240621C00005000 OCASPS Call American 100 5 BATO 2024-06-21
O:EBS240621C00002500 OCASPS Call American 100 2.5 BATO 2024-06-21
O:EBS240621P00002000 OPASPS Put American 100 2 BATO 2024-06-21
O:EBS240621P00001500 OPASPS Put American 100 1.5 BATO 2024-06-21
O:EBS240621P00001000 OPASPS Put American 100 1 BATO 2024-06-21
O:EBS240621P00000500 OPASPS Put American 100 0.5 BATO 2024-06-21
O:EBS240621C00002000 OCASPS Call American 100 2 BATO 2024-06-21
O:EBS240621C00001500 OCASPS Call American 100 1.5 BATO 2024-06-21
O:EBS240621C00001000 OCASPS Call American 100 1 BATO 2024-06-21
O:EBS240621C00000500 OCASPS Call American 100 0.5 BATO 2024-06-21
O:EBS240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:EBS240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:EBS240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:EBS240517P00002000 OPASPS Put American 100 2 BATO 2024-05-17
O:EBS240517P00001500 OPASPS Put American 100 1.5 BATO 2024-05-17
O:EBS240517P00001000 OPASPS Put American 100 1 BATO 2024-05-17
O:EBS240517P00000500 OPASPS Put American 100 0.5 BATO 2024-05-17
O:EBS240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:EBS240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:EBS240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:EBS240517C00002000 OCASPS Call American 100 2 BATO 2024-05-17
O:EBS240517C00001500 OCASPS Call American 100 1.5 BATO 2024-05-17
O:EBS240517C00001000 OCASPS Call American 100 1 BATO 2024-05-17
O:EBS240517C00000500 OCASPS Call American 100 0.5 BATO 2024-05-17
O:EBS240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:EBS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:EBS240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:EBS240419P00002000 OPASPS Put American 100 2 BATO 2024-04-19
O:EBS240419P00001500 OPASPS Put American 100 1.5 BATO 2024-04-19
O:EBS240419P00001000 OPASPS Put American 100 1 BATO 2024-04-19
O:EBS240419P00000500 OPASPS Put American 100 0.5 BATO 2024-04-19
O:EBS240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:EBS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:EBS240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:EBS240419C00002000 OCASPS Call American 100 2 BATO 2024-04-19
O:EBS240419C00001500 OCASPS Call American 100 1.5 BATO 2024-04-19
O:EBS240419C00001000 OCASPS Call American 100 1 BATO 2024-04-19
O:EBS240419C00000500 OCASPS Call American 100 0.5 BATO 2024-04-19
O:EBS240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:EBS240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:EBS240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:EBS240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:EBS240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:EBS240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:EBS240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:EBS240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:EBS240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:EBS240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:EBS240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:EBS240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:EBS240315P00002000 OPASPS Put American 100 2 BATO 2024-03-15
O:EBS240315P00001500 OPASPS Put American 100 1.5 BATO 2024-03-15
O:EBS240315P00001000 OPASPS Put American 100 1 BATO 2024-03-15
O:EBS240315P00000500 OPASPS Put American 100 0.5 BATO 2024-03-15
O:EBS240315C00002000 OCASPS Call American 100 2 BATO 2024-03-15
O:EBS240315C00001500 OCASPS Call American 100 1.5 BATO 2024-03-15
O:EBS240315C00001000 OCASPS Call American 100 1 BATO 2024-03-15
O:EBS240315C00000500 OCASPS Call American 100 0.5 BATO 2024-03-15
O:EBS240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:EBS240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:EBS240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:EBS240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:EBS240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:EBS240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:EBS240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:EBS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:EBS240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:EBS240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:EBS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:EBS240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:EBS231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:EBS231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:EBS231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:EBS231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:EBS231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:EBS231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:EBS231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:EBS231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:EBS231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:EBS231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:EBS231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:EBS231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:EBS231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:EBS231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:EBS231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:EBS231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:EBS231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:EBS231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:EBS231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:EBS231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:EBS231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:EBS231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:EBS231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:EBS231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:EBS231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:EBS231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:EBS231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:EBS231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:EBS231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:EBS231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:EBS231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:EBS231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:EBS230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:EBS230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:EBS230915P00020000 OPASPS Put American 100 20 BATO 2023-09-15
O:EBS230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:EBS230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:EBS230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:EBS230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:EBS230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:EBS230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:EBS230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:EBS230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:EBS230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:EBS230915C00020000 OCASPS Call American 100 20 BATO 2023-09-15
O:EBS230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:EBS230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:EBS230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:EBS230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:EBS230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:EBS230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:EBS230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:EBS230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:EBS230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:EBS230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:EBS230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:EBS230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:EBS230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:EBS230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:EBS230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:EBS230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:EBS230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:EBS230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:EBS230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
Flux d'actualités
News Oak Hill Advisors
OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing
Oak Hill Advisors (OHA) has provided a $250 million term loan facility to Emergent BioSolutions Inc. (EBS) to refinance its existing credit facility. The new debt financing is a crucial step in Emergent's plan to stabilize its financial profile.
GlobeNewswire Inc. • Il y a 3 jours
News Emergent BioSolutions
Pourquoi l'action Emergent BioSolutions monte en flèche aujourd'hui
L'action d'Emergent BioSolutions a bondi après que le Centre européen de prévention et de contrôle des maladies a relevé le niveau de risque pour le mpox. Toutefois, l'auteur estime que l'action n'est pas à acheter en raison de la nature temporaire de l'augmentation des ventes et des défis commerciaux actuels de l'entreprise.
The Motley Fool • Il y a 3 semaines
News Emergent BioSolutions
Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED) - Emergent ... - Benzinga
Emergent BioSolutions received over $250 million in contract modifications from the U.S. Department of Health and Human Services to deliver millions of doses of medical countermeasures for anthrax, smallpox, and botulism. These contract modifications will help ensure a continued supply of critical medical countermeasures to address biological threats and emergencies.
Benzinga • Il y a 2 mois
Stocks Business Contracts
Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services (HHS), to deliver millions of doses of four medical countermeasures (MCMs). These contract modifications will help ensure continued supply/stockpiling of critical MCMs to address biological threats and emergencies against anthrax, smallpox and botulism.
GlobeNewswire Inc. • Il y a 2 mois
Stocks Business Contracts
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd. (“Bora”, TWSE: 6472), a leading international pharmaceutical services company, for a total value of approximately $30 million. The Camden site, which is part of Emergent’s Contract Development and Manufacturing Organization (CDMO), has clinical and commercial non-viral aseptic fill/finish services on four fill lines, including lyophilization, formulation development, and support services. Alongside the facility, approximately 350 current Emergent employees are expected to join Bora as part of the transaction.
GlobeNewswire Inc. • Il y a 2 mois
Calendar Calendar of Events
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- In recognition of National Naloxone Awareness Day, Emergent BioSolutions Inc. (NYSE: EBS) is highlighting its ongoing efforts to combat the opioid epidemic in the U.S., including topline results from its new general population awareness survey on consumers’ understanding of opioid-related accidental overdose and fentanyl. The results show that there is a high level of awareness that fentanyl is an opioid, and that naloxone can reverse opioid overdoses, including those caused by fentanyl.1 It also found that there are still gaps in certain age groups and populations in understanding the role of naloxone in reversing opioid overdoses related to fentanyl.1
GlobeNewswire Inc. • Il y a 3 mois
Stocks Restructuring / Recapitalization
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities, and restructures its enterprise workforce to improve the performance and profitability of its business. Emergent will continue to focus on its core products business – medical countermeasures and NARCAN® Nasal Spray –and on delivering for its patients and customers, including the U.S. and allied governments.
GlobeNewswire Inc. • Il y a 4 mois
Stocks Business Contracts
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
GlobeNewswire Inc. • Il y a 4 mois
Calendar Calendar of Events
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
GAITHERSBURG, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first quarter 2024, key business updates, revenue guidance for the second quarter of 2024, and financial outlook for full year 2024.
GlobeNewswire Inc. • Il y a 4 mois
Health Health
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
GAITHERSBURG, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to fighting the ongoing opioid crisis by broadening access to, and awareness of, NARCAN® Nasal Spray to help save lives in opioid overdose emergencies. In 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported over 107,000 overdose deaths – a number that has risen almost every year and which has continued to break annual records.1 This includes a rise in synthetic opioid overdoses mainly driven by fentanyl.1 There is an inherent risk of potential overdose, wherever opioids are present, which has tragically become the leading cause of accidental death in the U.S.2 These statistics only further underscore the need for multi-sectoral action to address and prevent opioid overdose deaths.
GlobeNewswire Inc. • Il y a 5 mois
Voir tous
Actualités liées
Dernières actualités

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT